Open AccessSafety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)
Author(s) -
V.S. Moiseyev
Publication year - 2002
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.2001.3158
Subject(s) - medicine , levosimendan , myocardial infarction , cardiology , heart failure , placebo , randomized controlled trial , alternative medicine , pathology
To evaluate the safety and efficacy of levosimendan in patients with left ventricular failure complicating acute myocardial infarction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom